SCHEMBL2051799

SCHEMBL2051799

CC1(C)CCN(C(=O)O)c2cc([N+](=O)[O-])ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
HTT P42858 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
FFAR4 Q5NUL3 1/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
LMNA P02545 4/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
APAF1 O14727 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
MCL1 Q07820 1/20 0.39
ESPL1 Q14674 1/20 0.39
HSPA9 P38646 1/20 0.39
RARA P10276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4872661 0.89 LMNA (0.44) ALDH1A1SMN1; SMN2HTTLMNAGAA
SCHEMBL13416586 0.89 NOTUM (0.44) ALDH1A1SMN1; SMN2HTTL3MBTL1TDP1
SCHEMBL14507881 0.85 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HTTFFAR4LMNA
SCHEMBL4425583 0.84 FFAR4 (0.38) ALDH1A1SMN1; SMN2HTTFFAR4RXRA
SCHEMBL17242404 0.83 NOTUM (0.44) ALDH1A1SMN1; SMN2HTTL3MBTL1FFAR4
SCHEMBL17242405 0.83 NOTUM (0.44) ALDH1A1SMN1; SMN2HTTL3MBTL1FFAR4
SCHEMBL397120 0.83 LMNA (0.42) ALDH1A1SMN1; SMN2LMNAMAPTPOLB
SCHEMBL396958 0.82 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2HTTFFAR4LMNA
SCHEMBL17242352 0.81 NOTUM (0.47) ALDH1A1SMN1; SMN2HTTL3MBTL1FFAR4
SCHEMBL17242354 0.81 NOTUM (0.47) ALDH1A1SMN1; SMN2HTTL3MBTL1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107501099-A The adjusting control agent of ATP combination cassette transporters 沃泰克斯药物股份有限公司 2017-12-22 CN disclosed
CN-104788328-B The adjusting control agent of ATP combination cassette transporters 沃泰克斯药物股份有限公司 2017-09-12 CN disclosed
CN-103641765-B ATP-combines the adjusting control agent of cassette transporters 沃泰克斯药物股份有限公司 2016-08-17 CN disclosed
CN-104788328-A Modulators of ATP-binding cassette transporters VERTEX PHARMA 2015-07-22 CN disclosed
CN-101891680-B Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-10-29 CN disclosed
CN-103641765-A Modulators of ATP-binding cassette transporters VERTEX PHARMA 2014-03-19 CN disclosed
CN-101935301-B Modulators of ATP-binding cassette transporters VERTEX PHARMA 2013-10-16 CN disclosed
EP-2509954-A1 4 -OXO- 1H -QUINOLINE- 3 - CARBOXAMIDES AS MODULATORS OF ATP -BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2012-10-17 EP disclosed
CN-102652128-A 4-Oxo-1H-quinoline-3-carboxamides as modulators of ATP-binding cassette transporters VERTEX PHARMA 2012-08-29 CN disclosed
WO-2011072241-A1 4 -OXO- IH -QUINOLINE- 3 - CARBOXAMIDES AS MODULATORS OF ATP -BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-16 WO disclosed
CN-101935301-A Modulators of ATP-binding cassette transporters VERTEX PHARMA 2011-01-05 CN disclosed
CN-101891680-A The adjusting control agent of ATP- combination cassette transporters VERTEX PHARMA 2010-11-24 CN disclosed
CN-101006076-B Modulators of ATP-binding cassette transporters VERTEX PHARMA 2010-09-29 CN disclosed
EP-1974212-A1 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH Vertex Pharmaceuticals Incorporated (US) 2008-10-01 EP disclosed
CN-101006076-A Modulators of ATP-binding cassette transporters VERTEX PHARMA (US) 2007-07-25 CN disclosed
WO-2007075946-A1 COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-07-05 WO disclosed